{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:01Z","timestamp":1791544201457,"version":"4.3.4"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Esophageal cancer (EC) is a highly lethal malignancy characterized by the uncontrolled proliferation of cancerous cells within the esophagus. Despite recent advancements in therapeutic strategies, the prognosis remains poor, underscoring the urgent need for novel preventive and therapeutic approaches. Notably, several oncogenic viruses have been implicated in EC pathogenesis, prompting the exploration of epitope-based vaccines through immunoinformatics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Using immunoinformatics and bioinformatics approaches, we designed a novel multi-epitope vaccine targeting viral agents associated with EC. Protein sequences of ten viral candidates were retrieved from the UniProt database and evaluated for antigenicity using the VaxiJen server. Five highly antigenic proteins derived from Human Cytomegalovirus (HCMV), Human Papillomavirus (HPV), Human Herpesvirus 8 (HHV-8), Human Immunodeficiency Virus (HIV), and Epstein\u2013Barr Virus (EBV) were selected. T cell (CTL and HTL) and B cell (LBL) epitopes were predicted and screened for immunogenicity, allergenicity, and toxicity. The final vaccine construct incorporated \u03b2-defensin as an adjuvant and included 3 HTL, 8 CTL, and 8 LBL epitopes. Molecular docking and molecular dynamics (MD) simulations were conducted to assess the binding affinity of the vaccine with Toll-like receptor 3 (TLR3). In silico cloning was also performed using the pET-28a(+) vector in\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      strain K12.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The designed vaccine was found to be antigenic, non-allergenic, and non-toxic. Molecular docking revealed strong binding affinity between the vaccine construct and TLR3, which was further supported by MD simulation results indicating stable complex formation. Codon optimization and in silico cloning confirmed the high expression potential of the vaccine in the\n                      <jats:italic>E. coli<\/jats:italic>\n                      expression system.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The in silico analyses suggest that the developed multi-epitope vaccine construct is a promising candidate for preventing EC associated with viral infections. While these findings are encouraging, further experimental validation through in vitro and in vivo studies is essential to confirm the vaccine's safety, immunogenicity, and protective efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1587224","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T01:29:21Z","timestamp":1751938161000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Immuno-informatics analyses of important esophageal cancer associated viruses for multi-epitope vaccine design"],"prefix":"10.3389","volume":"16","author":[{"given":"Zafer Saad Al","family":"Shehri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3390\/cancers15030765","article-title":"Current status and future prospects for esophageal cancer","volume":"15","author":"Sheikh","year":"2023","journal-title":"Cancers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01727","article-title":"Understanding esophageal cancer: the challenges and opportunities for the next decade","volume":"10","author":"Yang","year":"2020","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003420","article-title":"Global esophageal cancer epidemiology in 2022 and predictions for 2050: A comprehensive analysis and projections based on GLOBOCAN data","volume":"137","author":"Qi","year":"2024","journal-title":"Chin Med J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.gtc.2016.04.001","article-title":"Esophageal cancer","volume":"45","author":"Alsop","year":"2016","journal-title":"Gastroenterol Clinics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2016.10.005","article-title":"Esophageal cancer: risk factors, genetic association, and treatment","volume":"41","author":"Huang","year":"2018","journal-title":"Asian J Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.21037\/acs.2017.03.03","article-title":"Overview of esophageal cancer","volume":"6","author":"Abbas","year":"2017","journal-title":"Ann cardiothor Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.226450","article-title":"Barrett esophagus and risk of esophageal cancer: a clinical review","volume":"310","author":"Spechler","year":"2013","journal-title":"Jama"},{"key":"B8","article-title":"Epidemiologic risk factors for esophageal cancer development","volume":"12","author":"Mao","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/cancers13010141","article-title":"Global burden, risk factors, and trends of esophageal cancer: an analysis of cancer registries from 48 countries","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12328-020-01237-x","article-title":"Epidemiology of esophageal cancer: update in global trends, etiology and risk factors","volume":"13","author":"Uhlenhopp","year":"2020","journal-title":"Clin J Gastroenterol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-6169-0","article-title":"Dietary factors and risk of mortality among patients with esophageal cancer: a systematic review","volume":"20","author":"Sun","year":"2020","journal-title":"BMC Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtbi.2014.01.018","article-title":"A novel multi-epitope peptide vaccine against cancer: an in silico approach","volume":"349","author":"Nezafat","year":"2014","journal-title":"J Theor Biol"},{"key":"B13","first-page":"1","article-title":"Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly","volume":"19","author":"Boon","year":"2019","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25667","article-title":"Identification of pathways and genes in the process of E6\/E7-induced carcinogenesis of esophageal epithelial cells","volume":"92","author":"Xia","year":"2020","journal-title":"J Med Virol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.5.4.363","article-title":"The Epstein-Barr virus is rarely associated with esophageal cancer","volume":"5","author":"Hong","year":"2000","journal-title":"Int J Mol Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01425.x","article-title":"Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan","volume":"94","author":"Wang","year":"1999","journal-title":"Off J Am Coll Gastroenterol| ACG"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.5812\/ijcm.114566","article-title":"Association of epstein\u2013barr virus and cytomegalovirus infections with esophageal carcinoma","volume":"14","author":"Sarvari","year":"2021","journal-title":"Int J Cancer Manage"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.24875\/AIDSRev.23000018","article-title":"HIV infection and esophageal cancer in Sub-Saharan Africa: a comprehensive meta-analysis","volume":"26","author":"Kamsu-Tchuente","year":"2024","journal-title":"AIDS Rev"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11938-023-00435-z","article-title":"Infective esophagitis: a review of esophageal diseases in HIV","author":"Ali","year":"2023","journal-title":"Curr Treat Opt Gastroenterol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins: Struct Funct Bioinf"},{"key":"B22","doi-asserted-by":"crossref","DOI":"10.1002\/jmr.893","article-title":"Predicting linear B-cell epitopes using string kernels","volume":"21","author":"EL-Manzalawy","year":"2008","journal-title":"J Mol Recogn: Interdiscip J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinf"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","article-title":"In silico approach for predicting toxicity of peptides and proteins","volume":"8","author":"Gupta","year":"2013","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1215","article-title":"A consensus epitope prediction approach identifies the breadth of murine T CD8+-cell responses to vaccinia virus","volume":"24","author":"Moutaftsi","year":"2006","journal-title":"Nat Biotechnol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6150-8-30","article-title":"Designing of interferon-gamma inducing MHC class-II binders","volume":"8","author":"Dhanda","year":"2013","journal-title":"Biol direct"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-7-153","article-title":"Predicting population coverage of T-cell epitope-based diagnostics and vaccines","volume":"7","author":"Bui","year":"2006","journal-title":"BMC Bioinf"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz452","article-title":"IEDB-AR: immune epitope database\u2014analysis resource in 2019","volume":"47","author":"Dhanda","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/14.8.529","article-title":"Design of the linkers which effectively separate domains of a bifunctional fusion protein","volume":"14","author":"Arai","year":"2001","journal-title":"Protein Eng"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292413","article-title":"An integrated comparative genomics, subtractive proteomics and immunoinformatics framework for the rational design of a Pan-Salmonella multi-epitope vaccine","volume":"19","author":"Bhattacharjee","year":"2024","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3390\/vaccines10111850","article-title":"Designing of peptide based multi-epitope vaccine construct against gallbladder cancer using immunoinformatics and computational approaches","volume":"10","author":"Dar","year":"2022","journal-title":"Vaccines"},{"key":"B32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10989-022-10380-7","article-title":"A novel multiepitope vaccine against bladder cancer based on CTL and HTL epitopes for induction of strong immune using immunoinformatics approaches","volume":"28","author":"Jahangirian","year":"2022","journal-title":"Int J Pept Res Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"105782","DOI":"10.1016\/j.micpath.2022.105782","article-title":"A subtractive proteomics and immunoinformatics approach towards designing a potential multi-epitope vaccine against pathogenic Listeria monocytogenes","volume":"172","author":"Rahman","year":"2022","journal-title":"Microbial Pathogen"},{"key":"B34","doi-asserted-by":"publisher","first-page":"74","DOI":"10.6026\/97320630012074","article-title":"MFPPI\u2013multi FASTA protparam interface","volume":"12","author":"Garg","year":"2016","journal-title":"Bioinformation"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq551","article-title":"High-throughput prediction of protein antigenicity using protein microarray data","volume":"26","author":"Magnan","year":"2010","journal-title":"Bioinformatics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2174\/1573409915666190318121838","article-title":"VaxiJen dataset of bacterial immunogens: an update","volume":"15","author":"Zaharieva","year":"2019","journal-title":"Curr computer-aided Drug design"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/11.6.681","article-title":"SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments","volume":"11","author":"Geourjon","year":"1995","journal-title":"Bioinformatics"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki396","article-title":"SCRATCH: a protein structure and structural feature prediction server","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt458","article-title":"GalaxyRefine: Protein structure refinement driven by side-chain repacking","volume":"41","author":"Heo","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/prot.10286","article-title":"Structure validation by C\u03b1 geometry: \u03d5, \u03c8 and C\u03b2 deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins: Struct Funct Bioinf"},{"key":"B41","first-page":"75","article-title":"Limitations of structure evaluation tools errat","volume":"16","author":"Lengths","year":"2018","journal-title":"Quick Guidel Comput Drug Des"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm290","article-title":"ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins","volume":"35","author":"Wiederstein","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-14-S19-S1","article-title":"Disulfide by design 2.0: a web-based tool for disulfide engineering in proteins","volume":"14","author":"Craig","year":"2013","journal-title":"BMC Bioinf"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009862","article-title":"Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system","volume":"5","author":"Rapin","year":"2010","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2018.01.038","article-title":"TLR3 expression status predicts prognosis in patients with advanced thoracic esophageal squamous cell carcinoma after esophagectomy","volume":"216","author":"Sato","year":"2018","journal-title":"Am J Surg"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00065.2009","article-title":"TLR3-mediated NF-\u03baB signaling in human esophageal epithelial cells","volume":"297","author":"Lim","year":"2009","journal-title":"Am J Physiology-Gastrointest Liver Physiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.3748\/wjg.v17.i32.3745","article-title":"Overexpression of TLR3, TLR4, TLR7 and TLR9 in esophageal squamous cell carcinoma","volume":"17","author":"Sheyhidin","year":"2011","journal-title":"World J gastroenterol: WJG"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2. 2 web server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"Van Zundert","year":"2016","journal-title":"J Mol Biol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1298","DOI":"10.1002\/wcms.1298","article-title":"Using PyMOL as a platform for computational drug design","volume":"7","author":"Yuan","year":"2017","journal-title":"Wiley Interdiscip Reviews: Comput Mol Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkn860","article-title":"PDBsum new things","volume":"37","author":"Laskowski","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"B52","doi-asserted-by":"crossref","DOI":"10.1109\/SC.2006.54","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.1021\/ct300203w","article-title":"Improving the prediction of absolute solvation free energies using the next generation OPLS force field","volume":"8","author":"Shivakumar","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J Chem Phys"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gki376","article-title":"JCat: a novel tool to adapt codon usage of a target gene to its potential expression host","volume":"33","author":"Grote","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/vaccines9060658","article-title":"Integrated Core Proteomics, Subtractive proteomics, and immunoinformatics investigation to unveil a potential multi-epitope vaccine against schistosomiasis","volume":"9","author":"Rehman","year":"2021","journal-title":"Vaccines"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s005950050187","article-title":"Poor prognosis in esophageal cancer patients with postoperative complications","volume":"28","author":"Hirai","year":"1998","journal-title":"Surg Today"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-2935-4","article-title":"Outcome of patients with esophageal cancer: a nationwide analysis","volume":"20","author":"Chen","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"14736","DOI":"10.18632\/aging.103532","article-title":"Prognostic evaluation of esophageal cancer patients with stages I-III","volume":"12","author":"Qiu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.3.6.985","article-title":"Design of multi-epitope, analogue-based cancer vaccines","volume":"3","author":"Fikes","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-0002","article-title":"A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602)","volume":"19","author":"Slingluff","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-013-1516-5","article-title":"Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors","volume":"63","author":"Lennerz","year":"2014","journal-title":"Cancer immunol immunother"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.031","article-title":"Evaluation of tandem Chlamydia trachomatis MOMP multi-epitopes vaccine in BALB\/c mice model","volume":"35","author":"Jiang","year":"2017","journal-title":"Vaccine"},{"key":"B65","doi-asserted-by":"publisher","first-page":"66192","DOI":"10.18632\/oncotarget.11751","article-title":"Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence","volume":"7","author":"Mittendorf","year":"2016","journal-title":"Oncotarget"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw150","article-title":"Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide AE37 vaccine in breast cancer patients to prevent recurrence","volume":"27","author":"Mittendorf","year":"2016","journal-title":"Ann Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu211","article-title":"Final report of the phase I\/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients","volume":"25","author":"Mittendorf","year":"2014","journal-title":"Ann Oncol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/1078-0432.CCR-08-1231","article-title":"Immunogenicity and antitumor effects of vaccination with peptide vaccine+\/\u2013 GM-CSF and\/or interferon \u03b12b in advanced metastatic melanoma: the ECOG phase II trial E1696","volume":"15","author":"Kirkwood","year":"2009","journal-title":"Clin Cancer research: an Off J Am Assoc Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/nm0398-321","article-title":"Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma","volume":"4","author":"Rosenberg","year":"1998","journal-title":"Nat Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2867","article-title":"Efficacy and safety analysis of nelipepimut-S vaccine to prevent breast cancer recurrence: a randomized, multicenter, phase III clinical trial","volume":"25","author":"Mittendorf","year":"2019","journal-title":"Clin Cancer Res"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0135-y","article-title":"Personalized vaccines use tumour fingerprint to target glioblastoma","volume":"15","author":"Ridler","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"106128","DOI":"10.1016\/j.compbiomed.2022.106128","article-title":"Designing a vaccine-based therapy against Epstein-Barr virus-associated tumors using immunoinformatics approach","volume":"150","author":"Omoboyede","year":"2022","journal-title":"Comput Biol Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2302116","DOI":"10.1002\/advs.202302116","article-title":"mRNA-based vaccines targeting the T-cell epitope-rich domain of Epstein Barr virus latent proteins elicit robust anti-tumor immunity in mice","volume":"10","author":"Zhao","year":"2023","journal-title":"Adv Sci"},{"key":"B74","doi-asserted-by":"publisher","first-page":"12397","DOI":"10.1038\/s41598-021-91997-4","article-title":"Design of a multi-epitope vaccine against cervical cancer using immunoinformatics approaches","volume":"11","author":"Sanami","year":"2021","journal-title":"Sci Rep"},{"key":"B75","doi-asserted-by":"publisher","first-page":"100986","DOI":"10.1016\/j.imu.2022.100986","article-title":"Immunoinformatics guided design of a next generation epitope-based vaccine against Kaposi Sarcoma","volume":"31","author":"Hoque","year":"2022","journal-title":"Inf Med Unlocked"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s10529-020-03060-3","article-title":"In vivo delivery of a multiepitope peptide and Nef protein using novel cell-penetrating peptides for development of HIV-1 vaccine candidate","volume":"43","author":"Davoodi","year":"2021","journal-title":"Biotechnol Lett"},{"key":"B77","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/biology10100997","article-title":"Designing a multi-epitope vaccine against chlamydia trachomatis by employing integrated core proteomics, immuno-informatics and in silico approaches","volume":"10","author":"Aslam","year":"2021","journal-title":"Biology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/vaccines9111373","article-title":"Development of a candidate multi-epitope subunit vaccine against Klebsiella aerogenes: subtractive proteomics and immuno-informatics approach","volume":"9","author":"Umar","year":"2021","journal-title":"Vaccines"},{"key":"B79","doi-asserted-by":"publisher","first-page":"104795","DOI":"10.1016\/j.meegid.2021.104795","article-title":"Rational design of multimeric based subunit vaccine against Mycoplasma pneumonia: Subtractive proteomics with immunoinformatics framework","volume":"91","author":"Mahmood","year":"2021","journal-title":"Infect Genet Evol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.molimm.2019.04.030","article-title":"In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma","volume":"112","author":"Safavi","year":"2019","journal-title":"Mol Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.016","article-title":"Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches","volume":"38","author":"Safavi","year":"2020","journal-title":"Vaccine"},{"key":"B82","doi-asserted-by":"crossref","first-page":"25331","DOI":"10.1038\/s41598-024-76798-9","article-title":"Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses","volume":"14","author":"Cao","year":"2024","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2013.11.009","article-title":"In addition to its antiviral and immunomodulatory properties, the zebrafish \u03b2-defensin 2 (zfBD2) is a potent viral DNA vaccine molecular adjuvant","volume":"101","author":"Garc\u00eda-Valtanen","year":"2014","journal-title":"Antiviral Res"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3390\/medicina58101356","article-title":"Designing mRNA-and peptide-based vaccine construct against emerging multidrug-resistant Citrobacter freundii: a computational-based subtractive proteomics approach","volume":"58","author":"Naveed","year":"2022","journal-title":"Medicina"},{"key":"B85","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3390\/vaccines9030293","article-title":"Immuno-informatics analysis of PAKISTAN-based HCV subtype-3a for chimeric polypeptide vaccine design","volume":"9","author":"Ahmad","year":"2021","journal-title":"Vaccines"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244176","article-title":"Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches","volume":"15","author":"Tahir ul Qamar","year":"2020","journal-title":"PloS One"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2018.06.080","article-title":"Scrutinizing Mycobacterium tuberculosis membrane and secretory proteins to formulate multiepitope subunit vaccine against pulmonary tuberculosis by utilizing immunoinformatic approaches","volume":"118","author":"Chatterjee","year":"2018","journal-title":"Int J Biol macromol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2019.08.259","article-title":"Development of a conserved chimeric vaccine based on helper T-cell and CTL epitopes for induction of strong immune response against Schistosoma mansoni using immunoinformatics approaches","volume":"141","author":"Rahmani","year":"2019","journal-title":"Int J Biol macromol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1883111","article-title":"Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches","volume":"40","author":"Mahdevar","year":"2022","journal-title":"J Biomol Struct Dynam"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26826","article-title":"Role of Toll-like receptors in the pathogenesis of COVID-19","volume":"93","author":"Khanmohammadi","year":"2021","journal-title":"J Med Virol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","article-title":"Modified lentiviral globin gene therapy for pediatric \u03b20\/\u03b20 transfusion-dependent \u03b2-thalassemia: A single-center","volume":"31","author":"Li","year":"2024","journal-title":"single-arm pilot trial"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00268","article-title":"Experimental validation of multi-epitope peptides including promising MHC class I-and II-restricted epitopes of four known Leishmania infantum proteins","volume":"5","author":"Agallou","year":"2014","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142563","article-title":"Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB\/c mice","volume":"10","author":"Ghaffari-Nazari","year":"2015","journal-title":"PloS One"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2014.11.001","article-title":"Production of a novel multi-epitope peptide vaccine for cancer immunotherapy in TC-1 tumor-bearing mice","volume":"43","author":"Nezafat","year":"2015","journal-title":"Biologicals"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1587224\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T01:29:23Z","timestamp":1751938163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1587224\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2025.1587224"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1587224","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"article-number":"1587224"}}